ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although we previously reported that BCR-ABL strongly inhibits cDC development from an early stage of haematopoiesis in a mouse CML model22, the effects on differentiation and function of myeloid cells, including cDC1s, in CML patients remains unclear.